WHO guideline for tuberculosis 2020?
Updated WHO guidelines emerging from this review, published in June 2020, recommend a shorter treatment regimen for patients with MDR/RR-TB not resistant to fluoroquinolones (of 9–11 months), with the inclusion of bedaquiline instead of an injectable agent, making the regimen all oral.
WHO guidelines TB treatment?
The initial phase should consist of 2 months of isoniazid, rifampicin, pyrazinamide and ethambutol. The continuation phase should consist of 4 months of isoniazid and rifampicin. Daily dosing should be used throughout treatment. The doses of anti-TB agents should conform to WHO’s recommendations.
WHO recommended treatment of malaria?
Artemisinin-based combination therapies (ACTs) are the recommended treatments for uncomplicated falciparum malaria. The following ACTs are recommended: – Artemether + lumefantrine; artesunate + amodiaquine; artesunate + mefloquine; artesunate + sulfadoxine-pyrimethamine, and dihydroartemisinin + piperaquine .
WHO TB prophylaxis guidelines?
The following options are recommended for the treatment of LTBI regardless of HIV status: 6 or 9 months of daily isoniazid, or a 3-month regimen of weekly rifapentine plus isoniazid, or a 3 month regimen of daily isoniazid plus rifampicin.
WHO TB publishing?
Key publications
- Tuberculosis in the WHO European Region: factsheet (2021)
- Tuberculosis elimination in the WHO European Region (2020)
- Review on palliative care with focus on 18 high tuberculosis priority countries, 2020.
- Quick guide to video-supported treatment of tuberculosis (2020)
WHO TB drug classification?
2. Classifications
| (1) WHO 2011 TB drugs classification | |
|---|---|
| Group 1 First-line oral anti-TB drugs | • Isoniazid • Rifampicin • Ethambutol • Pyrazinamide |
| Group 2 Injectable anti-TB drugs (injectable or parenteral agents) | • Streptomycin • Kanamycin • Amikacin • Capreomycin |
Which is the recommended treatment for TB?
The usual treatment is: 2 antibiotics (isoniazid and rifampicin) for 6 months. 2 additional antibiotics (pyrazinamide and ethambutol) for the first 2 months of the 6-month treatment period.
WHO TB classification?
Tuberculosis classification system
| Class | Type |
|---|---|
| 1 | TB exposure No evidence of infection |
| 2 | TB infection No disease |
| 3 | TB, clinically active |
| 4 | TB Not clinically active |
WHO criteria complicated malaria?
The definition of severe malaria relies upon WHO criteria revised in 2000. In children living in endemic areas, the most frequent criteria are impaired consciousness, severe anaemia, respiratory distress or acidosis, multiple convulsions and hypoglycaemia.
WHO TB Report India?
WHO estimates that some 4.1 million people currently suffer from TB but have not been diagnosed with the disease or have not officially reported to national authorities. This figure is up from 2.9 million in 2019.
WHO published the Global Tuberculosis Report of 2020?
Ministry of Health and Family Welfare
India TB Report 2020 :: Ministry of Health and Family Welfare.